Colony Bankcorp Reports Q1 2026 Earnings: Net Income $8.2 Million, Revenue $39.9 Million, EPS Misses Estimates

CBAN
April 23, 2026

Colony Bankcorp reported first‑quarter 2026 results with net income of $8.2 million and diluted earnings per share of $0.45. Revenue for the quarter was $39.9 million, falling short of the consensus estimate of $40.2 million and marking a miss on both earnings and revenue expectations.

The quarter’s net income represents a 25% year‑over‑year increase from $6.6 million in Q1 2025, while the diluted EPS of $0.45 missed the consensus estimate of $0.48 by $0.03. Revenue declined slightly from the $40.2 million analysts had projected, reflecting modest demand softness in the bank’s core fee‑income segments.

Net interest margin expanded to 3.48% from 2.93% in the prior year, driven by the integration of TC Federal Bank, higher yields on interest‑earning assets, and lower funding costs. The margin growth offsets the revenue miss and supports the company’s profitability trajectory.

Loans grew by $32.2 million sequentially to $2.41 billion, while deposits fell by $19.1 million to $3.05 billion, indicating modest loan growth and slight deposit pressure. The loan growth rate of 8% aligns with management’s guidance at the lower end of its 8‑12% target range.

Management reiterated guidance for a 1.20% return on assets in 2026 and confirmed a quarterly dividend of $0.12 per share. CEO T. Heath Fountain said, “We are pleased to welcome the TC Federal team and their customers to Colony,” highlighting the cultural alignment and strategic expansion in Georgia and Florida markets.

Investors reacted negatively to the earnings miss, but the company’s margin expansion, guidance, and dividend increase provide some confidence in its long‑term execution strategy.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.